Company Analysis

Vicore Pharma Holding AB (VCRE)

Nasdaq: VCRE · Pharmaceutical Preparations · filing with the SEC since 2026
Grade5.3
◀ Past 6.0● Present 5.1▶ Future 5.0
8 est.

Filings

13 filings since 2017 · read from EDGAR on Nov 13, 2026
Due next
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.

Filings a yearinsider forms included
13
2026

2026 counts to Nov 13, 2026.

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 6-K Interim report, foreign filer Nov 30, 2026
Nov 3, 2026 6-K Interim report, foreign filer Nov 30, 2026
Oct 22, 2026 6-K Interim report, foreign filer Oct 31, 2026
Oct 13, 2026 SCHEDULE 13G Large holder notice
Sep 30, 2026 6-K Interim report, foreign filer
Aug 21, 2026 S-8 Employee stock plan registration
Aug 21, 2026 6-K Interim report, foreign filer
Jul 6, 2026 6-K Interim report, foreign filer
Jun 30, 2026 SEC STAFF ACTION Form SEC STAFF ACTION
Jun 30, 2026 CERT Exchange listing certification
Jun 9, 2026 20FR12B/A Form 20FR12B/A
May 22, 2026 20FR12B Form 20FR12B
Apr 17, 2026 DRS Draft registration, confidential

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton VCRE · research, not advice